Journal of Clinical Oncology· 2013Q1· Guideline
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- 4,070citations
- Q1SCImago
- 2013year
Short summary
New ASCO/CAP guidelines update criteria for HER2 testing in breast cancer, defining HER2-positive status by protein overexpression (IHC) or gene amplification (ISH) in >10% of tumor cells, and recommending reflex testing for equivocal results.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Oncology
OncologyMedicine